Skip to main content

UNC to Lead Study of New Option for Some Colon Cancer Patients

March 28, 2011

CHAPEL HILL, N.C. – UNC Lineberger Comprehensive Cancer Center will lead a clinical trial to test a new option for colorectal cancer patients whose cancer has not responded to first line therapies. Almost 40 percent of patients whose cancers test positive for mutant K-RAS or BRAF genes see their cancers continue to progress on the … Continued

Multivitamin Use Doesn’t Impact Colon Cancer Outcomes

September 7, 2010

CHAPEL HILL, NC – As many as 30 percent of Americans take multivitamins in the belief that they will help prevent and treat chronic diseases such as cancer. Among cancer survivors, between 26 and 77 percent report using multivitamins. Given these significant numbers, a group of researchers, including UNC’s Richard Goldberg, MD, decided to test … Continued